Quest Diagnostics Incorporated (DGX)
Company Info
Highlights
$19.87B
$7.90
22.53
1.56
$10.16B
$3.31B
$1.95B
$132.78 - $179.32
$183.92
4.10%
2.41
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Quest Diagnostics Incorporated (DGX) returned 19.13% year-to-date (YTD) and 25.80% over the past 12 months. Over the past 10 years, DGX had an annualized return of 11.40%, slightly ahead of the S&P 500 benchmark at 10.89%.
DGX
19.13%
8.65%
12.01%
25.80%
12.65%
11.40%
^GSPC (Benchmark)
1.30%
12.79%
1.49%
12.35%
15.12%
10.89%
Monthly Returns
The table below presents the monthly returns of DGX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 8.64% | 6.01% | -2.14% | 5.85% | -0.14% | 19.13% | |||||||
| 2024 | -6.36% | -2.76% | 6.58% | 4.40% | 2.74% | -3.59% | 4.52% | 10.31% | -1.10% | 0.22% | 5.06% | -7.25% | 11.77% |
| 2023 | -4.66% | -6.82% | 2.26% | -1.40% | -4.44% | 5.96% | -3.31% | -2.74% | -7.33% | 7.38% | 5.48% | 0.47% | -10.05% |
| 2022 | -21.62% | -2.78% | 4.26% | -1.72% | 5.36% | -5.25% | 3.20% | -8.24% | -2.09% | 17.72% | 5.69% | 3.04% | -7.35% |
| 2021 | 8.86% | -10.50% | 11.03% | 3.25% | -0.16% | 0.23% | 7.95% | 7.78% | -4.92% | 1.45% | 1.29% | 16.36% | 47.86% |
| 2020 | 4.15% | -4.17% | -24.29% | 38.18% | 7.42% | -3.65% | 12.03% | -12.46% | 2.92% | 7.21% | 1.51% | -3.88% | 14.11% |
| 2019 | 5.56% | -0.92% | 3.89% | 7.81% | -0.49% | 6.15% | 0.78% | 0.28% | 4.55% | -4.92% | 5.23% | 0.23% | 31.13% |
| 2018 | 7.93% | -2.62% | -2.67% | 1.42% | 5.27% | 3.20% | -1.58% | 2.10% | -1.88% | -12.38% | -5.89% | -5.98% | -13.84% |
| 2017 | 0.51% | 6.01% | 0.77% | 7.95% | 3.09% | 2.20% | -2.17% | 0.04% | -13.58% | 0.63% | 4.99% | 0.03% | 9.16% |
| 2016 | -7.17% | 1.31% | 7.40% | 5.79% | 2.66% | 5.49% | 6.60% | -4.10% | 2.68% | -3.77% | 7.39% | 5.08% | 31.90% |
| 2015 | 6.49% | -1.31% | 9.57% | -6.60% | 5.33% | -3.60% | 2.32% | -8.14% | -9.34% | 11.23% | 0.54% | 4.13% | 8.37% |
| 2014 | -1.38% | 0.95% | 9.28% | -2.91% | 7.08% | -2.00% | 4.68% | 3.45% | -4.00% | 5.15% | 2.92% | 2.68% | 28.05% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 89, DGX is among the top 11% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Quest Diagnostics Incorporated provided a 1.71% dividend yield over the last twelve months, with an annual payout of $3.05 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $3.05 | $2.96 | $2.79 | $3.26 | $2.42 | $2.21 | $2.12 | $1.95 | $1.80 | $1.58 | $1.47 | $1.29 |
Dividend yield | 1.71% | 1.96% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% |
Monthly Dividends
The table displays the monthly dividend distributions for Quest Diagnostics Incorporated. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.75 | $0.00 | $0.00 | $0.80 | $0.00 | $1.55 | |||||||
| 2024 | $0.71 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $2.96 |
| 2023 | $0.66 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $2.79 |
| 2022 | $0.62 | $0.00 | $0.00 | $0.66 | $0.00 | $0.66 | $0.66 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $3.26 |
| 2021 | $0.56 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $2.42 |
| 2020 | $0.53 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $2.21 |
| 2019 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $2.12 |
| 2018 | $0.45 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $1.95 |
| 2017 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $1.80 |
| 2016 | $0.38 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.40 | $0.00 | $0.00 | $0.00 | $1.58 |
| 2015 | $0.33 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $1.47 |
| 2014 | $0.30 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $1.29 |
Dividend Yield & Payout
Dividend Yield
Quest Diagnostics Incorporated has a dividend yield of 1.71%, which is quite average when compared to the overall market.
Payout Ratio
Quest Diagnostics Incorporated has a payout ratio of 33.55%, which is quite average when compared to the overall market. This suggests that Quest Diagnostics Incorporated strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Quest Diagnostics Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Quest Diagnostics Incorporated was 49.46%, occurring on Feb 14, 2003. Recovery took 452 trading sessions.
The current Quest Diagnostics Incorporated drawdown is 0.30%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -49.46% | May 6, 2002 | 198 | Feb 14, 2003 | 452 | Dec 1, 2004 | 650 |
| -44.75% | Dec 29, 2000 | 57 | Mar 22, 2001 | 63 | Jun 21, 2001 | 120 |
| -36.6% | Mar 6, 2020 | 21 | Apr 3, 2020 | 15 | Apr 27, 2020 | 36 |
| -36.26% | Sep 1, 2006 | 536 | Oct 17, 2008 | 870 | Apr 2, 2012 | 1406 |
| -36.24% | Jun 10, 1998 | 85 | Oct 8, 1998 | 127 | Apr 13, 1999 | 212 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Quest Diagnostics Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Quest Diagnostics Incorporated, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 2.8% positive surprise.
Valuation
The Valuation section provides an overview of how Quest Diagnostics Incorporated is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for DGX, comparing it with other companies in the Diagnostics & Research industry. Currently, DGX has a P/E ratio of 22.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for DGX compared to other companies in the Diagnostics & Research industry. DGX currently has a PEG ratio of 1.6. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for DGX relative to other companies in the Diagnostics & Research industry. Currently, DGX has a P/S ratio of 2.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DGX in comparison with other companies in the Diagnostics & Research industry. Currently, DGX has a P/B value of 2.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |